IMM — ImmuPharma News Story

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Immupharma Selects Thermo Fisher Scientific As Drug Product CDMO For Kapiglucagon Program

22/07/2026 07:26

BRIEF-Immupharma Selects Thermo Fisher Scientific As Drug Product CDMO For Kapiglucagon Program

July 22 (Reuters) - ImmuPharma PLC IMM.L:

IMMUPHARMA - SELECTS THERMO FISHER SCIENTIFIC AS DRUG PRODUCT CDMO FOR KAPIGLUCAGON PROGRAM

Source text: ID:nRSV2794Na

Further company coverage: IMM.L